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Sleep duration is a novel and potentially modifiable risk factor for cancer. We evaluated the association 
of self‑reported sleep duration and daytime napping with odds of colorectal and gastric cancer. We 
included 2008 incident colorectal cancer cases, 542 gastric cancer cases and 3622 frequency‑matched 
population controls, recruited in the MCC‑Spain case–control study (2008–2013). Sleep information, 
socio‑demographic and lifestyle characteristics were obtained through personal interviews. 
Multivariable adjusted logistic regression models were used to estimate odds ratios (OR) with 95% 
confidence intervals (CI) for cancer, across categories of sleep duration (≤ 5, 6, 7, 8, ≥ 9 hours/day), 
daytime napping frequency (naps/week) and duration (minutes/nap). Compared to 7 hours of sleep, 
long sleep was associated with increased odds of colorectal  (OR≥9 hours: 1.59; 95%CI 1.30–1.94) and 
gastric cancer  (OR≥9 hours: 1.95; 1.37–2.76); short sleep was associated with increased odds of gastric 
cancer  (OR≤5 hours: 1.32; 0.93–1.88). Frequent and long daytime naps increased the odds of colorectal 
 (OR6–7 naps/week, ≥30 min: 1.32; 1.14–1.54) and gastric cancer  (OR6–7 naps/week, ≥30 min: 1.56; 1.21–2.02). Effects 
of short sleep and frequent long naps were stronger among participants with night shift‑work history. 
Sleep and circadian disruption may jointly play a role in the etiology of colorectal and gastric cancer.
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Colorectal cancer (CRC) is the third most common cancer worldwide (1,800,977 new cases in 2018), and the 
second most common cause of cancer death (861,663 deaths in 2018)1. Gastric cancer is the sixth most commonly 
diagnosed cancer (1,033,701 new cases) and third cause of cancer death (782,685 deaths)1. CRC incidence rates 
overall have declined since the mid-1980s because of changing patterns in risk factors and  screening2. However, 
CRC occurrence has been on the rise in patients younger than age 50 for unknown  reasons3. Despite extensive 
research on the etiology and advancements in early detection and treatment of colorectal and gastric tumors, 
more research on identifying modifiable risk factors is  needed2.
Sleep duration has been suggested as a novel and potentially modifiable risk factor for chronic disease inci-
dence and  mortality4–6. Specifically, short and long sleep duration have been associated with a higher risk for 
cardiovascular  disease7, type II  diabetes8,9,  obesity9,10 and  cancer11–13. Most studies of cancer so far have focused 
on the effects of sleep duration on breast cancer and the evidence on other tumors is  limited14,15. Long sleep 
duration has been associated with an increased risk of colorectal cancer in two prospective cohorts of health 
professionals, especially among individuals who were overweight or snored  regularly16. Long and short sleep 
were both associated with an elevated risk of CRC in a cohort study of postmenopausal  women17. So far only 
one study, a prospective cohort of older adults, has reported an increased risk for gastric cancer associated with 
short  sleep18. In a recent study prediagnosis short sleep and long napping were associated with significantly 
higher mortality among CRC  survivors19. No previous study has, to our knowledge, evaluated daytime napping 
as a risk factor for colorectal and gastric cancer.
Our aim in the present study was to evaluate habitual sleep duration and daytime napping in relation to colo-
rectal and gastric cancer adjusting for potential confounders and other sleep characteristics in a large population 
based case–control study. Long-term night shift work has been shown to increase the odds of colorectal and 
gastric cancer in our previous  analyses20,21. Therefore, we additionally conducted stratified analyses by night shift 
work history to evaluate potential joint effects of sleep and circadian disruption in relation to gastrointestinal 
cancer risk.
Methods
The MCC-Spain Study is a population-based case–control study on five tumors (breast, colorectal, prostate, 
stomach and chronic lymphocytic leukemia) in Spain, with the general aim to investigate environmental and 
genetic factors related to cancer risk. Methods used in this study have been previously reported in  detail22. In 
brief, the study recruited incident cancer cases from 23 hospitals in 12 different regions in Spain and a common 
set of population controls for all cases. The recruitment of cancer cases and controls study began in the year 2008 
and was conducted through 2013. All procedures performed in studies involving human participants were in 
accordance with the ethical standards of the research committee, and with the 1964 Helsinki Declaration and 
its later amendments or comparable ethical standards. The protocol of MCC-Spain was approved by each of the 
ethics committees of the participating institutions (Ethical Committee of Clinical Research of Barcelona, Canta-
bria, Girona, Gipuzkoa, Huelva, León, Principado de Asturias, Madrid, Navarra and Valencia). All participants 
provided informed consent prior to enrolment into the study. The data underlying this article cannot be shared 
publicly for the privacy of individuals that participated in the study. The data can be shared on reasonable request 
to the corresponding author and coordinator of the study.
Study population. Cases were males and females, aged 20–85  years with a new histological confirmed 
diagnosis of colorectal or gastric cancer living in the catchment area of each hospital for at least 6 months. Cases 
were defined by the International Classification of Disease 10 (ICD-10) codes: C18, C19, C20, D01.0, D01.1, 
D01.2 for colon or rectum, C16 and D00.2 for stomach and C15.5 for cancer cases of the lower third of the 
oesophagus. Clinical data such as CRC histological type (adenocarcinoma, mucinous adenocarcinoma, signet 
ring-cell carcinoma, squamous cell carcinoma, medullary carcinoma, undifferentiated carcinoma, other, type 
not specified), tumor localization (proximal colon, distal colon, rectum), and TNM staging information was 
available through hospital medical records. Most CRC tumors were adenocarcinomas (92% adenocarcinomas, 
5.5% mucinous carcinomas, 1.5% other types, 1% not specified). Most colorectal cancers (52%) were at clinical 
stage II or lower at recruitment, and in 110 patients (5.3%) we could not establish the clinical stage. Clinical data 
for gastric cancer included tumor histological type, localization, Lauren classification, the 2010 classification of 
the WHO and degree of differentiation Data on Helicobacter pylori (H. pylori) status were available in 279 cases, 
with 93% positive. Controls living in the same catchment area as cases for the same period of time (≥ 6 months) 
were randomly selected from the rosters of General Practitioners (GP) at the Primary Health Centers (PHC) 
included in the study. They were contacted on behalf of their GP and invited to participate in the study. Controls 
were frequency-matched to the overall distribution of cases, by age, sex and center, ensuring that in each center 
there was at least one control of the same sex and 5-year interval for each case. Eligible controls were free of 
CRC or gastric cancer history, respectively. Subjects were ineligible if they were incapable to participate in the 
interview due to communication difficulties (e.g. speaking problems) or excess impairment of physical ability. 
Response rates among cases and controls varied by center and on average were 68% among colorectal cancer 
cases, 55% among gastric cancer cases and 54% among controls with valid telephone numbers. There were no 
differences in educational level and age between those subjects who participated and those who did not respond 
to the study invitation or refused to participate. A total of 2140 CRC cases, 459 gastric cancer cases, 3950 controls 
for colorectal cancer and 3440 controls for gastric cancer were recruited in the study. Participants with missing 
information on sleep duration (N = 487, 7.3%) and key confounders (N = 7, 0.1%) were excluded. The present 
analysis included 2008 colorectal cancer cases, 452 gastric cancer cases, 3598 controls for colorectal cancer and 
3099 population controls for gastric cancer (3077 were common controls used in both analyses).
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Data collection. Participant information was collected using face-to-face interviews performed by trained 
personnel. Interviews with cancer patients were scheduled shortly after a new cancer diagnosis. The median 
time between date of diagnosis and interview was 63 days (interquartile range, iqr 106) for colorectal cancer and 
40 days (iqr 75) for gastric cancer. To evaluate sleep duration, subjects were asked to report how many hours 
on average they slept per night at the time of recruitment. They were also asked how frequently (days/week) 
they usually took daytime naps (“siestas”) and what was their average duration (minutes/nap). Sleep quality 
was assessed using questions on occurrence of sleep problems (difficulty falling asleep, waking up during the 
night, taking sleep medication) that lasted for at least 1 year through lifetime and also by reporting the the age 
of beginning and end of the sleep problem. Sleep timing was assessed asking participants to report their habitual 
bedtime, if they reported going to sleep at approximately the same time every day during the last 10 years, and 
whether they had experienced a period of at least 1 year with frequent changes in their bedtime. Night shift work 
(working for at least 3 h between midnight and 5am at least 3 times per month) was assessed using a lifetime 
occupational history and detailed questions on work schedules for all jobs held for at least a year. Information on 
known or suspected risk factors for colorectal and gastric cancer was collected including age, educational level, 
family socioeconomic level, race, BMI, family history of colorectal and gastric cancer, smoking status, physical 
activity, medication use, and personal disease history (e.g. diabetes). In a subset of participants (88% of controls, 
88% of colorectal cancer cases, 77% of gastric cancer cases) a self-administered diet questionnaire was used to 
assess current and past (at the age of 30–40 years) diet habits including alcohol consumption.
Statistical analysis. In bivariate analyses we examined participant’s characteristics by case–control sta-
tus and by categories of sleep duration and daytime napping. We used generalized additive models (GAM) 
to inspect the linearity of associations of sleep duration with CRC and gastric cancer. GAMs used a smooth-
ing function for sleep duration and were adjusted for confounders. We used unconditional logistic regression 
analysis and calculated odds ratios (OR) with 95% confidence intervals (CI) for colorectal and gastric cancer 
separately, across predefined categories of : (i) nighttime sleep duration (≤ 5 hours, 6 hours, 7 hours (reference), 
8 hours, ≥ 9 hours), (ii) daytime napping frequency (no napping (reference), 1–5 days/week, 6–7 days/week), (iii) 
daytime napping duration (no napping, < 15 min, 15–29 min, 30–59 min, ≥ 60 min), (iv) combined napping fre-
quency and duration (no napping, 1–5 naps/week for < 30  min, 6–7 naps/week for < 30  min, 1–5 naps/week 
for ≥ 30 min, 6–7 naps/week for ≥ 30 min). For the combined analysis, the median of napping duration (30 min) 
and the 25th percentile of napping frequency (5 days/week) among controls that napped were used as cut-offs. 
We also assessed the effects of ever having sleep problems (for at least 1 year), duration of sleep problems (years) 
and having experienced frequent changes in bedtime. Crude models were adjusted for frequency-matched vari-
ables (age, center, sex) and educational level (less than primary, primary, high school, university). Fully-adjusted 
models were additionally adjusted for family history of CRC or gastric cancer in first degree relatives (yes/no), 
body mass index (< 25, 25–29, ≥ 30 units), leisure time physical activity (inactive, little active, moderately active, 
very active)), smoking status (never, ex-smoker, current smoker) and occupational status (employed, unem-
ployed, housewives, retired). A category of missing values was used for confounders included in the final model. 
Full case-analysis was performed in a subset of participants (88% of controls, 88% of colorectal cancer cases, 77% 
of gastric cancer cases), with diet information on usual and past dietary intake. In this analysis we additionally 
adjusted for diet habits [past alcohol consumption (quartiles), total energy intake in grams/day (quartiles), red 
meat consumption in grams/day (quartiles), fruit consumption in grams/day (quartiles), vegetable consumption 
in grams/day (quartiles)], other sleep characteristics (sleep duration/daytime napping; sleep problems, frequent 
changes in bedtime), and night shift work history (never shift work, permanent night shifts, rotating night shifts, 
rotating shifts, housewives). Further adjustment to the above mentioned variables made minimal difference in 
risk estimates and these results are presented in Supplemental Table 1. We tested possible interactions between 
sleep duration/daytime napping and sex (women, men), BMI (< 25, 25–30, > 30), night shift work history (never, 
ever), education (primary school or less vs high school, university or higher) and age at recruitment/diagnosis 
(< 50 years, ≥ 50 years) using the likelihood ratio test (LRT) and performed stratified analyses. Stratified analysis 
by night shift work history (never, ever) was conducted among participants with night shift work information 
(87.5%), after excluding participants with missing night shift work history (CRC: 7.9%, gastric: 5.8%) and house-
wives (CRC/gastric: 6.7%). We also evaluated the association between sleep duration and daytime napping and 
anatomical subtypes (colon, rectum), and TNM staging (0–II, III, IV) of colorectal cancer and anatomical site 
(non-cardia/oesophageal, cardia) and Lauren classification (Intestinal vs Diffuse) for gastric cancer using mul-
tinomial logistic regression and tested for heterogeneity across subtypes of cancer. In sensitivity analysis we (i) 
excluded participants with any report of sleep problem in the 5 years prior to recruitment in the study (N = 1930, 
31.7%) (ii) excluded retired workers (N = 3146, 52%), (iii) excluded participants with more than 6  months 
between the date of diagnosis and interview. Analyses were performed using Stata version 14.1.
Compliance with ethical standards. Ethical approval was obtained from the local ethical committee. 
Informed consent was obtained from all participants. All methods were carried out in accordance with relevant 
guidelines and regulations.
Results
CRC cases were more likely to be older, obese, less physically active, to smoke, to have a lower educational level 
and to report CRC in their family history, than controls (Table 1). Similarly, gastric cancer cases were older and 
more likely to be obese, physically inactive, ever smokers, and to have family history of gastric cancer, compared 
to controls. Both colorectal and gastric cancer cases reported higher total energy intake, past alcohol consump-
tion and red meat consumption compared to their respective controls. Average sleep duration was slightly longer 
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among cases (CRC 7.3 h; SD1.6; gastric cancer 7.2 h; SD 1.6) than controls (7 h; SD 1.4). Daytime napping was 
reported among 61% of colorectal cancer cases, 60% of gastric cancer cases and approximately 55% of population 
controls. Both colorectal and gastric cancer cases were more likely to report a higher frequency (days/week) and 
duration (minutes/nap) of daytime napping compared to controls. Sleep problems and use of sleep medication 
was more frequent among controls than among cancer cases.
Controls in the extreme sleep duration categories (≤ 5 and ≥ 9 h) were more likely to be older and retired, 
have a higher BMI, lower education, and be less physically active, compared to those with 7 h of sleep (Table 2). 
Controls with the longest durations of sleep (≥ 9 h) were also more likely to be male, to have night shift work 
history and report higher past alcohol consumption, compared to participants with shorter sleep duration. 
Controls who slept ≤ 5 h were more likely to have sleep problems, take sleep medication, and report frequent 
changes in bed time. Daytime napping was less common in the extreme sleep duration categories, compared to 
the 7 h group, however frequency and duration of naps was higher in participants with extreme nighttime sleep 
duration, compared to 7 h of sleep. Participants napping 6–7 times a week were slightly older and more likely 
to be male, retired workers, smokers and less likely to have sleep problems. Sleep duration was similar between 
participants with and without napping and across categories of increasing napping frequency.
We found a U-shape association between sleep duration and gastric cancer as shown in the multivariable 
adjusted GAM spline (Fig. 1). A similar but less pronounced shape of association was observed for CRC. The 
quadratic term of sleep duration was statistically significant (p < 0.001) for both colorectal and gastric cancer 
risk, showing departure from linearity. Associations of sleep duration categories, daytime naps with incident 
colorectal and gastric cancer are presented in Table 3. In multivariable adjusted models sleep duration of 8 hours 
and ≥ 9 hours were associated with an increase in the odds of CRC  (OR8 hours: 1.27; 95% CI 1.08–1.49,  OR≥9 hours: 
1.59; 1.30–1.94) and gastric cancer  (OR8 hours: 1.46; 95% CI 1.09–1.97,  OR≥9 hours: 1.95; 1.35–2.76), compared to 
Table 1.  Characteristics of controls and cases with sleep duration information in the MCC-Spain study 
(N = 6082). Some column totals do not add up due to missing data. BMI body mass index, METS metabolic 
equivalents, SD standard deviation. a 3077 of the controls are common controls for colorectal and gastric 
cancer. b Study subset (3193 colorectal cancer controls, 1773 colorectal cancer cases, 349 gastric cancer cases 
and 2732 gastric cancer controls). c Computed among participants who reported daytime napping.
Controls for colorectal cancer 
(N = 3598)a Colorectal cancer cases (N = 2008)
Controls for gastric cancer 
(N = 3099)a Gastric cancer cases (N = 452)
Characteristics
Age; mean (SD) 63.2 (11.8) 66.9 (10.8) 64.0 (11.5) 66.4 (12.4)
BMI (kg/m2); mean (SD) 26.7 (4.5) 27.5 (4.5) 26.9 (4.4) 27.6 (4.2)
Women (%) 49.4 36.3 45.2 33.0
Postmenopausal (%) 72.7 90.0 75.1 88.6
Obese (%) 21.1 25.5 21.5 25.7
Primary school or less (%) 52.3 69.1 54.0 68.8
Never smokers (%) 44.5 41.3 44.2 40.7
Physically inactive (METS hour/
week) (%) 40.7 48.9 42.0 50.7
Family history of colorectal cancer 
(%) 8.2 16.6 8.6 10.6
Family history of gastric cancer (%) 6.0 6.5 6.1 15.5
Night shift work history (%) 16.8 16.9 17.1 19.5
Retired (%) 48.0 58.1 51.6 53.5
Diet habits; mean (SD)b
Total energy intake (kcal/day) 1896 (637) 2010 (704) 1907 (640) 2183 (858)
Past alcohol consumption (g 
ethanol /day) 17.3 (27.0) 24.3 (34.1) 18.1 (27.5) 27.8 (24.2)
All red meat consumption (g/day) 61.8 (38.8) 74.0 (48.7) 62.9 (38.8) 84.6 (54.8)
Fruit consumption (g/day) 349 (217) 345 (204) 353 (218) 356 (234)
Vegetable consumption (g/day) 190 (123) 172 (109) 192 (126) 181 (126)
Sleep characteristics
Sleep duration; mean (SD) 7.0 (1.4) 7.3 (1.6) 7.0 (1.4) 7.2 (1.6)
Daytime napping (%) 54.6 61.2 56.6 59.7
Daytime napping frequency (days/
week); mean (SD)c 5.8 (2.0) 6.1 (1.8) 5.9 (2.0) 6.1 (1.8)
Daytime napping duration (min-
utes/day); mean (SD)c 34.3 (31.6) 42.4 (36.4) 35.4 (32.0) 42.4 (35.1)
Ever sleep problems (%) 36.1 33.6 34.8 28.8
Ever sleep medication (%) 21.1 18.0 20.5 16.7
Frequent changes in bed time (%) 18.4 19.2 18.2 18.8
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7 h of sleep. Short sleep (≤ 5 hours) was associated with non-significant increase in the odds of gastric cancer 
 (OR≤5 hours: 1.32; 95% CI; 0.93–1.88). Effects of short sleep on gastric cancer became stronger and statistically sig-
nificant in full case-analyses among participants with diet information after additionally adjusting for diet, sleep, 
and shift work history (Supplemental Table 1). Daytime napping frequency and duration were both significantly 
associated with higher odds of colorectal and gastric cancer, compared to those who did not nap (Table 3). Cancer 
odds were highest among those who reported napping frequently (CRC:  OR6-7 days/week: 1.24; 95% CI 1.09–1.42; 
gastric:  OR6-7 days/week 1.31; 95%CI 1.04–1.67) or longer (CRC:  OR>60 min: 1.32; 95% CI 1.12–1.55; gastric:  OR>60 min 
1.60; 95%CI 1.21–2.11). Mutually adjusting sleep duration for napping and vice-versa had minimal impact on the 
respective risk estimates (not shown). In combined analyses of napping frequency/duration the odds of cancer 
significantly increased among participants that reported frequent (6–7 naps/week) and longer (30 min) naps 
(CRC:  OR6-7 days/week, ≥30 min: 1.32; 95% CI 1.14–1.54; gastric:  OR6-7 days/week, ≥30 min: 1.56, 95%CI 1.21–2.02) and not 
for the other combinations of frequency and duration. The effects of long sleep duration and daytime napping on 
both tumors remained statistically significant and became stronger in full case-analysis among participants with 
diet information and after several additional adjustments for diet factors, sleep characteristics, and night shift 
work history (Supplemental Table 1). Sleep problems, duration of sleep problems (years) and frequent changes in 
time of sleep were not associated with colorectal or gastric cancer (Supplemental Table 2). In stratified analysis by 
BMI categories, long sleep was associated with a larger increase in CRC odds among individuals with BMI < 25 
(colorectal:  OR≥9 hours: 2.21, 1.55–3.16) than among overweight (BMI = 25–30:  OR≥9 hours 1.38; 1.01–1.87) and 
obese (BMI > 30:  OR≥9 hours: 1.40; 0.93–2.09) participants (Table 4). We found no important variation in CRC 
risk estimates for daytime napping across BMI strata. On the contrary, the strongest effects on gastric cancer 
of extreme sleep durations and daytime napping were observed among overweight (BMI: 25–30) participants 
(p-for-interaction with sleep duration = 0.002).  
In stratified analysis by lifetime night shift work history, short sleep was associated with a significantly 
increased odds of colorectal  (OR≤5 hours: 1.69, 95%CI 1.04–2.74) and gastric cancer  (OR≤5 hours: 2.75; 95%CI 
1.15–6.59) among participants with night shift work history (LRT p-for interaction = 0.11) (Table 5). Long sleep 
duration (8 h and ≥ 9 h) was associated with higher odds of colorectal and gastric cancer of similar magnitude, 
Table 2.  Characteristics of sleep duration and daytime napping profiles among all controls included in the 
analysis of colorectal cancer (N = 3598). a Computed among participants with reported daytime napping. BMI 
body mass index, METS metabolic equivalents, SD standard deviation, iqr interquartile range.
Characteristics
Sleep duration (hours/day) (N = 3598) Daytime napping frequency (N = 3496)
 ≤ 5 6 7 8  ≥ 9 No naps Napping 1–5 days/week Napping 6–7 days/week
N 472 724 1048 987 368 1534 555 1407
Age; mean (SD) 65.1 (10.7) 62.5 (11.4) 60.4 (11.9) 63.7 (11.9) 68.8 (10.4) 62.1 (12.3) 58.4 66.4 (10.0)
BMI; mean (SD) 27.3 (4.7) 27.2 (4.6) 26.2 (4.2) 26.5 (4.3) 27.7 (4.8) 26.6 (4.6) 26.1 (4.2) 27.2 (4.3)
Women (%) 51.1 49.5 50.9 49.2 42.9 59.1 50.8 36.5
Obese (%) 23.9 23.8 16.8 19.6 28.5 20.6 16.8 23.6
Primary school or less (%) 65.3 51.7 41.8 49.4 74.2 54.4 38.0 56.0
Never smoker (%) 49.8 39.6 42.8 44.6 51.9 50.3 38.6 40.4
Physically Inactive (METS hour/week) 
(%) 44.5 43.1 36.5 39.6 45.9 40.7 36.6 42.9
Family history of colorectal cancer (%) 9.5 8.9 8.1 8.1 5.7 8.2 7.2 8.5
Family history of gastric cancer (%) 6.7 5.7 5.9 5.7 7.1 6.8 5.4 5.3
Night shift work history (%) 16.7 17.1 16.4 15.6 20.7 16.2 16.6 17.8
Retired (%) 50.0 45.5 38.4 52.8 65.2 41.1 36.2 60.5
Diet habits; mean (SD)
Total energy intake (kcal/day) 1850 (744) 1872 (586) 1941 (663) 1873 (583) 1927 (654) 1856 (629) 1914 (628) 1941 (653)
Past alcohol consumption (g ethanol /
day) 16.6 (27.9) 17.4 (28.1) 17.1 (25.3) 16.8 (26.2) 20.4 (30.8) 13.4 (22.9) 17.1 (26.3) 22.0 (30.4)
All red meat consumption (g/day) 57.9 (38.3) 61.4 (35.9) 65.0 (39.5) 62.2 (41.2) 57.3 (35.4) 59.2 (37.6) 66.8 (39.9) 63.3 (39.9)
Fruit consumption (g/day) 352 (218) 340 (205) 346 (234) 357 (210) 348 (209) 359 (216) 325 (205) 349 (224)
Vegetable consumption (g/day) 195 (141) 183 (105) 188 (113) 188 (123) 207 (156) 192 (129) 193 (128) 186 (113)
Sleep characteristics
Sleep duration (mean; SD) – – – – 7.0 (1.4) 6.9 (1.2) 7.1 (1.4)
Daytime napping (%) 53.4 54.6 54.8 56.2 51.4
Daytime napping frequency (days/week); 
(mean; SD)a 5.9 (1.9) 5.8 (2.0) 5.4 (2.2) 5.9 (12.0) 6.4 (1.5) – 2.7 (1.3) 6.9 (0.2)
Daytime napping duration (minutes/
day); (median; iqr)a 21 (49) 20 (41) 20 (24) 30 (45) 30 (45) – 30 (45) 30 (45)
Ever sleep problems (%) 67.4 40.9 29.6 27.5 28.5 37.2 35.0 35.3
Sleep medication (%) 37.2 22.9 17.3 17.7 17.4 21.7 19.2 20.8
Frequent changes in bed time (%) 23.3 19.5 17.4 16.1 18.9 18.5 19.2 18.1
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compared to 7 h of sleep, in both strata. Regular long naps (6–7 days/week, ≥ 30 min) were associated with 
a greater increase in the odds of colorectal and gastric cancer among participants with night shift work his-
tory (CRC:  OR6-7 days/week, ≥30 min 1.75, 95%CI 1.23, 2.51; gastric:  OR6-7 days/week, ≥30 min 2.54, 95%CI 1.06–6.06), 
while a weaker or no association was described among participants with no shift work history (CRC: 
 OR6-7 days/week, ≥30min1.33, 95%CI 1.11–1.61; gastric:  OR6-7 days/week, ≥ 30 min 1.19; 0.87–1.63), although the statisti-
cal interaction between daytime naps and night work history was not significant.
In stratified analyses by sex, the association between sleep duration and cancer varied slightly across sexes 
(opposite direction for short and long sleep), but there was no evidence for a statistically significant sex-interac-
tion with sleep duration (Supplemental Table 3). Women in the top category of napping frequency and duration 
had a higher odds for gastric cancer than men (LRT p-for-interaction = 0.03). In analyses stratified by education 
associations of sleep duration and cancer were observed across both strata of education (primary or less/high 
school or more) (Supplemental Table 4). A finer analysis using 4 strata revealed a similar risk pattern for sleep 
duration (data not shown); results for 9 + hours of sleep were insignificant and weaker among those with the 
lowest education (less than primary) compared to the rest of the groups. Daytime napping results were stronger 
in the stratum with lowest education for CRC but results for gastric cancer were similar across strata of educa-
tion. In stratified analysis by age at diagnosis/interview, the effects of longer sleep duration and daytime napping 
on colorectal and gastric cancer were more pronounced among participants younger than 50 years than among 
those older than 50 years, but no statistically significant interaction was observed (Supplemental Table 5). Results 
for colorectal cancer showed no significant heterogeneity by TNM staging or anatomical site (Supplemental 
A. Sleep duration and colorectal cancer (p-Gain=0.0001)A




















0 2 4 6 8 10 12
Sleep duration
p=0.001
Figure 1.  Multivariable adjusted General Additive Model (GAM) splines for the association (smooth function) 
of sleep duration and colorectal (A) and gastric (B) cancer risk in the MCC-Spain study. (A) Sleep duration 
and colorectal cancer (p-Gain = 0.0001). (B) Sleep duration and gastric cancer (p-Gain = 0.0001). Adjusted 
for age (continuous), centre (Barcelona, Madrid, Leon, Navarra, Cantabria, Guipuzcoa, Valencia, Huelva, 
Asturias, Granada, Murcia),, sex (female, male), and educational level (less than primary, primary, high school, 
university), family history of colorectal cancer or gastric cancer in first degree relatives (yes/no), body mass 
index (< 22.5, 22.5–24.9, 25–29.9, ≥ 30), leisure time physical activity (inactive, little active, moderately active, 
very active), smoking status (never, ex-smoker, current smoker).
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Table 6). Associations with long sleep duration and napping were a bit stronger for stage IV colorectal cancer but 
also strong and significant for stage 0–II colorectal tumors. Most of the associations were retained in analyses 
by anatomical cancer site and Lauren’s classification categories for gastric cancer (Supplemental Table 7). Long 
sleep duration was associated with an increased odds for both tumors located in the colon and rectum, while 
most of the risk estimates did not differ between non-cardia and cardia/esophageal cancer. In sensitivity analyses 
excluding participants with report of sleep problems in the 5 years prior to recruitment, results were unchanged 
(Supplemental Table 8). After the exclusion of retired participants and participants with more than 6 months 
between the date of diagnosis and interview most results were unchanged or became stronger (data not shown).
Discussion
In this large case–control study we found that participants with longer sleep duration (8 hours and ≥ 9 hours) 
had significantly increased odds of colorectal and gastric cancer, compared to those with 7 hours of sleep. Short 
sleep duration (≤ 5 hours) was also associated with increased, but not statistically significant, gastric cancer odds. 
Frequent (6–7 days/week) long (> 60 min) naps were associated with increased odds of colorectal and gastric 
cancer. The effects of short sleep duration and napping were stronger among participants with night shift work 
history for both tumors.
Long sleep duration was independently associated with colorectal and gastric cancer in our study. Long 
sleep duration has been associated with higher all-cause and cancer-specific mortality in several meta-analyses 
including a large number of observational  studies4,23,24. To date, only a few studies have examined the association 
of sleep duration with cancer risk for tumors other than breast  cancer11,14. Our findings for an association of 
long sleep with CRC are in line with results from two prospective US cohorts of health professionals previously 
reported an increased risk of CRC among participants with sleep duration of 8 hours and ≥ 9 hours (compared to 
7 hours of sleep), especially among individuals who were overweight or snored  regularly16. Although we lacked 
Table 3.  Sleep duration and daytime napping in relation to colorectal and gastric cancer odds in the MCC-
Spain study. a OR adjusted for age (continuous), centre (Barcelona, Madrid, Leon, Navarra, Cantabria, 
Guipuzcoa, Valencia, Huelva, Asturias, Granada, Murcia), sex (female, male), and educational level (less than 
primary, primary, high school, university). b OR additionally adjusted for family history of colorectal cancer 
or gastric cancer in first degree relatives (yes/no), body mass index (< 22.5, 22.5–24.9, 25–29.9, ≥ 30), leisure 
time physical activity (inactive, little active, moderately active, very active), smoking status (never, ex-smoker, 
current smoker) and current occupational status (employed, unemployed, housewife, retired).
Sleep duration (hours)










OR [CI 95%]a OR [CI 95%]b(n) % (n ) % (n) % (n ) %
 ≤ 5 472 13.1 259 12.9 1.05 (0.87, 1.28) 1.05 (0.86, 1.28) 419 13.5 68 15.0 1.29 (0.91, 1.83) 1.32 (0.93, 1.88)
6 723 20.1 337 16.8 0.98 (0.82, 1.17) 0.97 (0.81, 1.17) 624 20.1 70 15.5 0.99 (0.71, 1.39) 0.95 (0.68, 1.34)
7 1048 29.1 457 22.8 1.00 (Ref) 1.00 (Ref) 876 28.3 92 20.3 1.00 (Ref) 1.00 (Ref)
8 987 27.4 601 29.9 1.26 (1.08, 1.47) 1.27 (1.08, 1.49) 852 27.5 136 30.1 1.40 (1.05, 1.87) 1.46 (1.09, 1.97)
 ≥ 9 368 10.2 354 17.6 1.56 (1.29, 1.90) 1.59 (1.30, 1.94) 328 10.6 86 19.0 1.88 (1.33, 2.64) 1.95 (1.37, 2.76)










No naps 1533 43.9 738 37.5 1.00 (Ref) 1.00 (Ref) 1323 43.5 174 39.2 1.00 (Ref) 1.00 (Ref)
1–2 302 8.6 128 6.5 1.02 (0.81, 1.30) 1.00 (0.79, 1.28) 236 7.8 32 7.2 1.25 (0.82, 1.92) 1.20 (0.78, 1.85)
3–5 253 7.3 139 7.1 1.13 (0.89, 1.42) 1.15 (0.91, 1.46) 203 6.7 25 5.6 0.96 (0.61, 1.52) 0.99 (0.62, 1.58)
6–7 1407 40.3 961 48.9 1.25 (1.10, 1.43) 1.24 (1.09, 1.42) 1281 42.1 213 48.0 1.26 (1.00, 1.58) 1.31 (1.04, 1.67)
Frequency (cont; per day/week) 1.03 (1.02, 1.05) 1.03 (1.01, 1.05) 1.03 (1.00, 1.06) 1.04 (1.01, 1.07)










No naps 1533 44.6 738 39.9 1.00 (Ref) 1.00 (Ref) 1323 44.3 174 39.5 1.00 (Ref) 1.00 (Ref)
 < 15 269 7.8 103 5.6 0.79 (0.62, 1.02) 0.81 (0.63, 1.05) 226 7.6 28 6.3 0.97 (0.63, 1.50) 1.07 (0.69, 1.67)
15–29 432 12.6 230 12.4 1.06 (0.88, 1.28) 1.05 (0.86, 1.27) 372 12.4 43 9.8 0.90 (0.63, 1.29) 0.94 (0.65, 1.36)
30–60 546 15.9 321 17.3 1.19 (1.00, 1.41) 1.19 (1.00, 1.42) 490 16.4 82 18.6 1.33 (0.99, 1.79) 1.36 (1.00, 1.84)
 > 60 657 19.1 459 24.8 1.30 (1.11, 1.53) 1.32 (1.12, 1.55) 575 19.3 114 25.9 1.53 (1.17, 2.00) 1.60 (1.21, 2.11)
Duration (cont; per 30 min napping) 1.11 (1.06, 1.17) 1.12 (1.06, 1.18) 1.14 (1.05, 1.25) 1.14 (1.04, 1.24)
Daytime napping frequency and duration combined
No naps 1533 44.6 738 39.9 1.00 (Ref) 1.00 (Ref) 1323 44.3 174 39.5 1.00 (Ref) 1.00 (Ref)
1–5 naps/week, < 30 min 193 5.6 81 4.4 0.95 (0.71, 1.26) 0.95 (0.71, 1.27) 147 4.9 13 3.0 0.79 (0.43, 1.44) 0.83 (0.45, 1.53)
6–7 naps/week, < 30 min 508 14.8 252 13.6 0.97 (0.81, 1.16) 0.97 (0.80, 1.16) 451 15.1 58 13.2 0.97 (0.70, 1.35) 1.00 (0.74, 1.45)
1–5 naps/week, ≥ 30 min 350 10.2 166 9.0 1.08 (0.87, 1.35) 1.09 (0.88, 1.36) 280 9.4 44 10.0 1.31 (0.91, 1.91) 1.29 (0.88, 1.89)
6–7 naps/week, ≥ 30 min 853 24.8 614 33.2 1.32 (1.14, 1.53) 1.32 (1.14, 1.54) 785 26.3 152 34.5 1.48 (1.15, 1.91) 1.56 (1.21, 2.02)
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information on snoring or sleep disordered breathing, our results did not change after adjusting for BMI/obe-
sity and impaired sleep quality, two surrogates of sleep apnoea. Long sleep exhibited a stronger effect on CRC 
among individuals with a normal BMI. This may indicate that mechanisms other than increased adiposity—a 
well-known risk factor for CRC and gastric cancer—might be involved in the potential link between long sleep 
and cancer. A 40% increase in risk of CRC was associated with sleep durations of 10 + hours/day in a cohort of 
Table 4.  Sleep duration and daytime napping in relation to colorectal and gastric cancer odds in the 
MCC-Spain study by BMI categories. a p-for interaction (sleep duration) = 0.25, p-for-interaction (daytime 
napping) = 0.28. b p-for interaction(sleep duration) = 0.002, p-for-interaction(daytime napping) = 0.70. c OR 
adjusted for age (continuous), sex, centre (Barcelona, Madrid, Leon, Navarra, Cantabria, Guipuzcoa, Valencia, 
Huelva, Asturias, Granada, Murcia), sex (female, male), educational level (less than primary, primary, high 
school, university), family history of colorectal cancer or gastric cancer in first degree relatives (yes/no), body 
mass index (continuous), leisure time physical activity (inactive, little active, moderately active, very active), 
smoking status (never, ex-smoker, current smoker) and current occupational status (employed, unemployed, 
housewife, retired).
BMI categories










OR [CI 95%]c(n) % (n ) % (n) % (n ) %
BMI < 25
Sleep duration (hours)
 ≤ 5 165 12.3 67 11.0 0.96 (0.65, 1.35) 138 12.8 15 11.7 0.72 (0.36, 1.45)
6 242 18.0 103 17.1 1.18 (0.85, 1.62) 197 18.2 26 20.3 1.19 (0.66, 2.14)
7 428 31.8 137 22.5 1.00 (Ref) 335 31.0 33 25.8 1.00 (Ref)
8 395 29.4 186 30.6 1.24 (0.93, 1.64) 322 29.8 30 23.4 0.83 (0.47, 1.47)
 ≥ 9 116 8.6 114 18.8 2.21 (1.55, 3.16) 90 8.3 24 18.8 1.95 (1.01, 3.74)
Daytime napping frequency and duration
No naps 625 48.7 243 41.1 1.00 (Ref) 517 49.7 60 47.2 1.00 (Ref)
1–5 naps/week, < 30 min 89 6.9 33 5.9 1.09 (0.69, 1.71) 63 6.1 6 4.7 0.81 (0.30, 2.16)
6–7 naps/week, < 30 min 167 13.0 70 12.5 1.04 (0.75, 1.46) 142 13.6 17 13.4 1.15 (0.62, 2.11)
1–5 naps/week, ≥ 30 min 146 11.4 49 8.8 0.93 (0.63, 1.36) 112 10.8 14 11.0 1.01 (0.51, 2.00)
6–7 naps/week, ≥ 30 min 256 20.0 164 29.3 1.34 (1.02, 1.77) 207 19.9 30 23.6 1.33 (0.78, 2.24)
BMI = 25–30
Sleep duration (hours)
 ≤ 5 194 13.0 111 12.5 0.97 (0.71, 1.31) 177 13.4 32 15.4 1.92 (1.11, 3.32)
6 309 20.7 142 16.0 0.86 (0.65, 1.13) 267 20.2 31 14.9 1.30 (0.77, 2.23)
7 444 29.8 221 24.9 1.00 (Ref) 385 29.1 33 15.9 1.00 (Ref)
8 399 26.7 272 30.6 1.25 (0.99, 1.59) 355 26.8 68 32.7 2.19 (1.46, 3.66)
 ≥ 9 147 9.8 143 16.1 1.38 (1.01, 1.87) 137 10.4 44 21.2 3.16 (1.85, 5.38)
Daytime napping frequency and duration
No naps 592 41.6 323 36.9 1.00 (Ref) 526 41.5 75 36.9 1.00 (Ref)
1–5 naps/week, < 30 min 73 5.1 28 3.4 0.69 (0.42, 1.12) 62 4.9 4 2.0 0.57 (0.20, 1.66)
6–7 naps/week, < 30 min 246 17.3 117 14.2 0.86 (0.65, 1.13) 216 17.0 26 13.0 0.88 (0.53, 1.45)
1–5 naps/week, ≥ 30 min 142 10.0 68 8.2 1.02 (0.72, 1.44) 113 8.9 17 8.5 1.20 (0.66, 2.18)
6–7 naps/week, ≥ 30 min 371 26.0 289 35.0 1.40 (1.12, 1.76) 351 27.7 78 39.0 1.77 (1.21, 2.59)
BMI > 30
Sleep duration (hours)
 ≤ 5 113 14.9 81 15.8 1.20 (0.80, 1.80) 99 14.9 21 18.1 1.03 (0.51, 2.05)
6 172 22.7 92 18.0 0.93 (0.64, 1.36) 156 23.5 13 11.2 0.45 (0.21, 0.95)
7 176 23.2 99 19.3 1.00 (Ref) 148 22.3 26 22.4 1.00 (Ref)
8 193 25.4 143 27.9 1.31 (0.92, 1.86) 168 25.3 38 32.8 1.17 (0.64, 2.12)
 ≥ 9 105 13.8 97 18.9 1.40 (0.93, 2.09) 94 14.1 18 15.5 1.06 (0.51, 2.20)
Daytime napping frequency and duration
No naps 316 43.3 172 36.8 1.00 (Ref) 272 42.1 39 34.2 1.00 (Ref)
1–5 naps/week, < 30 min 31 4.2 20 4.3 1.22 (0.65, 2.30) 22 3.4 3 2.6 1.04 (0.27, 3.94)
6–7 naps/week, < 30 min 95 13.0 65 13.9 1.11 (0.75, 1.65) 88 13.6 15 13.2 1.39 (0.69, 2.81)
1–5 naps/week, ≥ 30 min 62 8.5 49 10.5 1.53 (0.96, 2.43) 54 8.3 13 11.4 1.99 (0.91, 4.32)
6–7 naps/week, ≥ 30 min 226 31.0 161 34.5 1.20 (0.88, 1.63) 212 32.7 44 38.6 1.60 (0.95, 2.71)
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female  teachers25. Our study extends these findings to both sexes and to the general population across occu-
pational groups. Both long (≥ 9 hours) and short (≤ 5 hours) sleep have been associated with an increase in the 
incidence of CRC among postmenopausal  women17. In our study, short sleep (≤ 5 hours) was associated with 
borderline higher odds of gastric cancer, but not CRC. Previous studies have identified associations of short 
sleep with all-cause mortality, cancer-specific mortality and cancer  incidence12. In line with our results, a US 
cohort of older adults (the NIH-AARP Diet and Health Study) reported a significantly increased gastric cancer 
risk in male short (5–6 hours)  sleepers18. Our findings for short sleep duration and gastric cancer are also sup-
ported by a recent Mendelian Randomization study that analysed 22-site specific cancers among UK Biobank 
participants and reported suggestive associations of genetic liability to short sleep duration with higher odds of 
several gastrointestinal cancers including gastric, pancreatic and CRC 26.
Daytime napping frequency and duration were associated with increasing odds of colorectal and gastric can-
cer, with highest odds observed in participants with frequent (6–7 naps/week) and long (≥ 30 min) naps. When 
napping analyses were further adjusted for sleep duration and other sleep characteristics results were robust, 
indicating independent association with cancer. This is the first study to examine the role of daytime napping—
commonly known as “siesta”—in relation to colorectal and gastric cancer risk. In a previous study no napping 
was associated with a greater all-cancer incidence in males, compared to < 30 min napping, but longer napping 
durations (30 + min) were also associated with a higher cancer  risk27. Similarly in our data, gastrointestinal cancer 
odds increased among participants reporting longer naps (≥ 30 min) but not among those with shorter napping 
duration (< 30 min) independently of napping frequency. Interestingly, in a study including 4869 CRC survivors, 
prediagnostic napping was associated with higher total and cardiovascular disease-specific  mortality19. The role 
of daytime napping and its frequency and duration in modifying the association of sleep needs to be explored 
in future studies of cancer and other chronic disease outcomes.
In stratified analysis by night shift work history we found a stronger effect of short sleep and napping among 
subjects with night shift work history, and this risk pattern was consistent for both colorectal and gastric cancer. 
Sleep disruption is one of the suggested mechanisms for the link between night shift work and cancer  risk28. 
While in our previous analyses long-term night shift work has been shown to increase the odds of gastric and 
 colorectal20,21, the present study suggests that short sleep duration and napping may interact with shift work with 
joint effects on gastrointestinal cancer risk. Although in our study, sleep problems could not be attributed to night 
shift work, our findings corroborate with a few other studies suggesting combined effects of long-term night shift 
work and long sleep duration on total cancer incidence and  mortality27, breast  cancer29 and lung  cancer30. Night 
shift work leads to acute sleep loss and impaired sleep  quality31,32, compensational daytime napping on work days 
and longer sleep on days  off6,32,33. Shift work related sleep disturbances may become chronic and persist even after 
quitting shift  work34, and in  retirement35. Shift workers who are especially vulnerable to shift work schedules are 
more likely to develop “shift work sleep disorder” (SWD) which consists of chronic insomnia and/or daytime 
 sleepiness36. However it is currently unknown if shift workers with SWD are at a greater risk of developing later 
chronic diseases compared to shift workers without  SWD37. Our results suggest that participants with short sleep 
and daytime naps may be more susceptible to the negative effects of night work. Alternatively participants with 
night shift work history that develop sleep problems might be at a higher risk of colorectal and gastric cancer, 
compared to night workers without sleep complaints. Our finding of joint effects between circadian and sleep 
disruption is novel and needs to be confirmed in prospective cohort studies.
Animal and human studies suggest a genetic basis for sleep duration, thus, short and long sleepers may rep-
resent phenotypes of the function of clock genes in human  sleep38–40. Experimental data provide a physiological 
basis for the inter-individual variability and the intra-individual stability of habitual sleep  duration38. Sleep is well 
known for its contribution to the maintenance of the immune system and regulation of human  metabolism41,42. 
Several mechanisms for the negative effects of long sleep on mortality have been suggested and discussed by 
Grander and  Drummond43 and many of them may have implications for cancer outcomes: First, reported long 
sleep might reflect disturbances in sleep continuity or sleep architecture and thus may result from impaired 
sleep quality or fragmented  sleep44. Second, long sleep has been associated with feelings of fatigue and lethargy 
which in turn may decrease resistance to stress and disease. Third, long sleep may influence the immune system 
and expression of  cytokines45–47. Fourth long sleep may be associated with shorter photoperiod and inadequate 
light exposure  patterns48. Fifth, long sleep has been consistently associated with a more sedentary behaviour, less 
healthy lifestyle and  obesity49–52. Furthermore, long sleepers were found more likely to be divorced, living alone, 
unemployed, and have a lower socioeconomic  status50. Sixth, depression or other underlying chronic disease 
such as sleep apnoea or diabetes that lead to longer sleep or longer time in bed may mediate the association 
between long sleep and cancer. Last, there is a possibility that poor health including cancer leads to long sleep 
rather than the  opposite43. On the other hand, several biological mechanisms may explain the potential link 
between short sleep with cancer risk. Sleep deprivation has been associated with impaired immune function, 
elevated levels of inflammatory markers and deregulation of cortisol levels that may affect the tumor surveillance 
 system53–55. Specifically for gastric cancer, a disrupted immune–inflammation balance might promote H. pylori 
related gastric  carcinogenesis41. Sleep deficiency has been also linked to higher adiposity, metabolic syndrome 
and type II diabetes that may in turn further increase the risk of  cancer56–58. Furthermore, short sleep duration 
might be related to increased light-at-night exposure and thus lower nocturnal melatonin  levels38, a hormone with 
well-known direct and indirect oncostatic  properties59,60. Finally, sleep loss and/or circadian misalignment may 
be associated with gut microbiota disruption and subsequent increased risk for metabolic disease and CRC 61,62.
Our study has several limitations. First, reverse causality could partly explain some of the observed associa-
tions since cancer status may affect sleep duration and napping habits in both directions (towards more but also 
less sleep). Similar to most previous epidemiological studies, we assessed current sleep duration and assumed it 
to be representative of habitual and past sleep duration during adulthood within individuals, but likely reflects 
relatively recent exposures. In order to address this question, in a follow up of the MCC-Spain study additional 
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sleep information was collected at age 40 years and in the year prior to recruitment/cancer diagnosis among 
breast and prostate cancer cases and respective controls. In preliminary analysis, we found a significant correla-
tion between sleep durations at age 40 and in the year before diagnosis and results did not vary by case–control 
status (data not shown). These results are supportive of our assumption that current sleep duration assessed 
in late adulthood could be indicative of past sleep duration in mid adulthood. Furthermore, in our study only 
incident cases were recruited and interviews were scheduled soon after cancer diagnoses. Our results did not 
change when we excluded interviews that took place 6 months or later after cancer diagnoses (data not shown). 
In order to reduce the potential for reverse causality, we conducted sensitivity analyses excluding participants 
with sleep problems in the 5 years before diagnosis/recruitment, which did not materially change the results. 
In addition, we found no evidence for significant risk variation across colorectal cancer stages in TNM stage-
stratified analyses. Second, self-reported sleep duration estimates may contain error and are in poor or moderate 
Table 5.  Sleep duration and daytime napping in relation to colorectal and gastric cancer odds in the MCC-
Spain study by night shift work history. a p-for interaction (sleep duration) = 0.21, p-for-interaction(daytime 
napping) = 0.77. b p-for interaction(sleep duration) = 0.30, p-for-interaction(daytime napping) = 0.38. c OR 
adjusted for age (continuous), sex (male, female), centre (Barcelona, Madrid, Leon, Navarra, Cantabria, 
Guipuzcoa, Valencia, Huelva, Asturias, Granada, Murcia),, educational level (less than primary, primary, high 
school, university), family history of colorectal cancer or gastric cancer in first degree relatives (yes/no), body 
mass index (< 22.5, 22.5–24.9, 25–29.9, ≥ 30), leisure time physical activity (inactive, little active, moderately 
active, very active), smoking status (never, ex-smoker, current smoker) and current occupational status 
(employed, unemployed, housewife, retired).
Night shift work history Colorectal  cancera Gastric  cancerb
Never night shift work
Controls (N = 2557) Cases (N = 1262)
OR [CI 95%]c
Controls (N = 2180) Cases (N = 305)
OR [CI 95%]c(n) % (n ) % (n) % (n ) %
Sleep duration (hours)
 ≤ 5 326 12.8 153 12.1 0.98 (0.76, 1.25) 292 13.4 41 13.4 1.11 (0.73, 1.71)
6 518 20.3 211 16.7 0.95 (0.76, 1.18) 442 20.3 47 15.4 0.85 (0.57, 1.28)
7 796 31.1 318 25.2 1.00 (Ref) 660 30.3 74 24.3 1.00 (Ref)
8 701 27.4 387 30.7 1.27 (1.05, 1.54) 602 27.6 95 31.2 1.43 (1.02, 2.01)
 ≥ 9 216 8.5 193 15.3 1.76 (1.37, 2.27) 184 8.4 48 15.7 2.22 (1.44, 3.43)
Daytime napping frequency and duration combined
No naps 1072 43.3 454 37.0 1.00 (Ref) 910 42.6 124 41.6 1.00 (Ref)
1–5 naps/week, < 30 min 150 6.1 60 4.9 0.94 (0.67, 1.31) 116 5.4 9 3.0 0.64 (0.31, 1.32)
6–7 naps/week, < 30 min 371 15.0 174 14.2 0.96 (0.77, 1.20) 327 15.3 39 13.1 0.86 (0.57, 1.28)
1–5 naps/week, ≥ 30 min 273 11.0 127 10.4 1.14 (0.88, 1.47) 218 10.2 31 10.4 1.00 (0.64,1.57)
6–7 naps/week, ≥ 30 min 610 24.6 411 33.5 1.33 (1.11, 1.61) 564 26.4 95 31.9 1.19 (0.87, 1.63)
Ever night shift work Controls (N = 605) Cases (N = 339) Controls (N = 503) Cases (N = 88)
Sleep duration (hours)
 ≤ 5 79 13.1 52 15.3 1.69 (1.04, 2.74) 65 12.9 18 20.5 2.75 (1.15, 6.59)
6 124 20.5 58 17.1 1.16 (0.73, 1.83) 102 20.3 13 14.8 1.40 (0.60, 3.43)
7 172 28.4 68 20.1 1.00 (ref) 140 27.8 12 13.6 1.00 (Ref)
8 154 25.5 102 30.1 1.60 (1.06, 2.41) 128 25.5 26 29.6 2.27 (1.01, 5.11)
 ≥ 9 76 12.6 59 17.4 1.54 (0.95, 2.51) 68 13.5 19 21.6 2.53 (1.06, 6.06)
Daytime napping frequency and duration combined
No naps 249 42.2 106 31.6 1.00 (Ref) 216 43.6 26 30.2 1.00 (Ref)
1–5 naps/week, < 30 min 32 5.4 15 4.5 1.40 (0.68, 2.85) 25 5.0 4 4.7 1.52 (0.43, 5.36)
6–7 naps/week, < 30 min 80 13.6 48 14.3 1.27 (0.80, 2.02) 75 15.2 10 11.6 1.31 (0.54, 3.16)
1–5 naps/week, ≥ 30 min 60 10.2 27 8.0 1.21 (0.70, 2.10) 43 8.7 9 10.5 3.25 (1.22, 8.68)
6–7 naps/week, ≥ 30 min 169 28.6 140 41.7 1.75 (1.23, 2.51) 136 27.5 37 43.0 2.97 (1.54, 5.72)
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agreement with objective (polysomnography or actigraphy) measurements in some but not all  studies63–65. Par-
ticipants might have provided information on how many hours they spend in bed instead of actual sleep time, 
although these two metrics tend to correlate. However, report of current sleep duration is unlikely differential 
between cases and controls since no recall of past exposure was involved and sleep duration is not a well-known 
risk factor for cancer, thus, exposure misclassification may have biased our estimates to the null. Third, sleep 
duration was missing in 8.8% of CRC controls, 9% in gastric cancer controls, 6.1% of CRC cases and 1.5% in 
gastric cancer cases, but no differences were found in age, BMI, family history of cancer between participants 
with and without sleep duration information. Missingness in sleep duration was associated with education and 
lifestyle (opposite pattern for cases and for controls) but in stratified analyses by education most results were 
robust. Fourth, we assessed habitual sleep duration once and did not record changes or sustained effects of sleep 
duration over time, although we controlled for frequent changes of sleeping time that could account for night-
to-night variability in sleep duration. Epidemiology is still limited due to constraints in measuring sleep with 
existing  questionnaires66, and future studies should include detailed sleep assessment over critical periods in 
life that would help reconstruct and evaluate a person’s “lifetime sleep history”67. Fifth, although our study was 
large, power was limited in stratified analyses, especially for gastric cancer. Sixth, although our study extensively 
controlled for potential confounders, residual confounding cannot be entirely ruled out. In addition, psychiatric 
conditions such as depression or anxiety were not assessed and thus not controlled for analytically. Last, similar 
to other population-based case–control studies low to moderate response rates were observed in both cases 
and controls, especially among gastric cancer patients due to poor disease prognosis. It is possible that gastric 
cancer patients with more advanced disease at diagnosis were underrepresented in our study. The reasons for 
the relatively low response rates may have differed between cases and controls and could have led to selection 
bias. Participants with a higher socioeconomic or educational status were more likely to participate in the study, 
especially among controls. However, we found no clear differences of the effects according to groups of educa-
tion, where selection bias potential would be minimized.
Strengths of this study include the large sample size with enough participants in the categories of extreme 
sleep duration (29% reported ≤ 5 h and 10% reported ≥ 9 h), the collection of information on a wide range of 
known and suspected risk factors for both tumors and extensive control for potential confounders, including 
other sleep characteristics such as sleep quality and sleep timing, to account for potential confounding due to 
impaired sleep. Most results were strong and consistent between colorectal and gastric cancer and remained 
significant after additional adjustments and in several stratified and sensitivity analyses, suggesting that our 
findings were unlikely entirely due to chance.
In this large population-based case–control study we described an association of long sleep duration (8 hours 
and ≥ 9 hours) with increased odds of colorectal and gastric cancer. Short sleep duration (≤ 5 hours) was associ-
ated with increased—but not statistically significant—odds of gastric cancer. Short sleep and daytime napping, 
especially frequent (6–7 days/week) long (≥ 30 min) naps, were associated with increased colorectal and gastric 
cancer odds, in particular among participants with night shift work history. Our findings support a potential 
role of extreme nighttime sleep duration and daytime napping in the odds of colorectal and gastric cancer and 
suggest possible joint effects of sleep and circadian disruption on the risk of gastrointestinal cancer.
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